New Active Pharmaceutical Ingredient-Ionic Liquids (API-ILs) Derived from Indomethacin and Mebendazole †
Abstract
Share and Cite
Fernandez-Stefanuto, V.; Tojo, E. New Active Pharmaceutical Ingredient-Ionic Liquids (API-ILs) Derived from Indomethacin and Mebendazole. Proceedings 2019, 9, 48. https://doi.org/10.3390/ecsoc-22-05781
Fernandez-Stefanuto V, Tojo E. New Active Pharmaceutical Ingredient-Ionic Liquids (API-ILs) Derived from Indomethacin and Mebendazole. Proceedings. 2019; 9(1):48. https://doi.org/10.3390/ecsoc-22-05781
Chicago/Turabian StyleFernandez-Stefanuto, Verónica, and Emilia Tojo. 2019. "New Active Pharmaceutical Ingredient-Ionic Liquids (API-ILs) Derived from Indomethacin and Mebendazole" Proceedings 9, no. 1: 48. https://doi.org/10.3390/ecsoc-22-05781